Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on November 15, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

HEalth care Rewards to Achieve Improved OutcomES (HEROES)

Closed
ARPA-H-SOL-24-01Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
Request for Information (RFI): Verification and Compliance Checking for Natural-Language Network Requirements (FastVacc)
Solicitation # DARPA-SN-27-13
The Defense Advanced Research Projects Agency (DARPA) Information Processing Techniques Office (IPTO) has issued a Request for Information (RFI) under solicitation number DARPA-SN-27-13 titled Verification and Compliance Checking for Natural-Language Network Requirements (FastVacc). The agency is seeking information on tools, practices, and approaches to reduce the time and cost of verifiable compliance checking for network security requirements by two to three orders of magnitude. The objective is to develop a capability that can process natural-language requirements documents, such as Zero Trust Architecture or Commercial Solutions for Classified packages, and concrete network configurations to identify inconsistencies, redundancies, and incompleteness in an offline phase, while providing near real-time verification of configurations with human-understandable output. This RFI is not a formal solicitation for proposals and does not constitute a binding contract. Interested respondents must submit their information by November 13, 2026, via email to [email hidden]. Submissions should consist of a one-page narrative and up to two slides featuring visual depictions of key concepts, including a completed version of Table 1. All responses must be submitted at the unclassified level in unprotected Microsoft Word, PowerPoint, or PDF formats, adhering to specific formatting guidelines including 12-point font and one-inch margins. Any proprietary information must be clearly labeled as Proprietary, and the use of the term Confidential is strictly prohibited for proprietary business data.
Defense Advanced Research Projects Agcy

POSTED

about 12 hours ago

DEADLINE

in 15 days
NAICS: 541715
New
Federal
FTA Broad Agency Announcement (FY26) -- “Research Initiatives in Support of Safety, Accessibility, and Mobility in Public Transportation
Solicitation # 693195-26-BAA-0001
The Federal Transit Administration (FTA) Office of Research, Demonstration, and Innovation has issued Broad Agency Announcement 693195-26-BAA-0001 to solicit applied research projects aimed at enhancing the safety, reliability, efficiency, and accessibility of public transportation in the United States. This unrestricted solicitation is open to any responsible source, excluding Federal Government-owned businesses, and encourages teaming and collaboration. The program focuses on technology readiness levels 3 through 6, with a specific preference for proof-of-concept testing. Research topics include community connectivity, accessibility for automated vehicles, urban rail innovations, ferry safety, and transit safety data analytics. Individual awards are typically valued between $150,000 and $500,000 and may be structured as firm-fixed-price or level-of-effort term contracts. While cost sharing is not mandatory, projects that include transit operator partnerships and cost sharing are preferred. The selection process is a two-phased approach starting with a five-page concept paper and a one-page quad chart, followed by a formal proposal for invited offerors. Evaluation is based on technical merit, importance to agency programs, and cost, with technical factors weighted significantly higher than price. The response deadline has been extended to October 30, 2026. Awardees must comply with various Federal Acquisition Regulation clauses, including Section 889 prohibitions on certain telecommunications and video surveillance equipment. Key deliverables include periodic reports, annual research summaries for multi-year projects, and a final technical report, all of which must be submitted 30 days prior to the end of the performance period.
693195 Office Of Acquisition Mgt

POSTED

about 12 hours ago

DEADLINE

in 8 days
NAICS: 541715
New
Federal
Bolstering Underutilized Industry by Leveraging Technology Transfer (BUILTT) pilot program
Solicitation # 10292026-LR-27
The Department of Energy, in partnership with the National Nuclear Security Administration, has announced the Bolstering Underutilized Industry by Leveraging Technology Transfer (BUILTT) pilot program. This initiative, conducted by the Nevada National Security Sites, Y-12 National Security Complex, and Kansas City National Security Campus, aims to assist qualified U.S. small and medium-sized businesses in manufacturing low-volume, high-impact technologies developed by DOE/NNSA Labs, Plants, and Sites. These technologies, which include specialized optical imaging, radiation and chemical sensing systems, precision electrical components, and advanced materials, often have limited commercial markets but are critical for government mission requirements. Under the program, selected businesses may receive a Cost Reduction License (CRL) for a nominal fee, granting them the rights to produce specified technologies for sale to the DOE, NNSA, and other government customers at pre-negotiated prices. Eligibility is limited to U.S.-based SMBs, with preference given to those near participating sites or those with SBA 8(a) or HUBZone designations. Interested parties are evaluated based on their technical and manufacturing capabilities, financial capacity, and ability to meet regulatory and security requirements. Responses must be submitted to the Technology Partnerships and Intellectual Property Office by April 1, 2027, and are categorized under NAICS code 541715.
Msts – DOE Contractor

POSTED

about 12 hours ago

DEADLINE

in 5 months
NAICS: 541715
New
Federal
REQUEST FOR INFORMATION – PACIFIC GREENFIELD INITIATIVE (ADVANCED MANUFACTURING AND INDUSTRIAL RESILIENCE OPPORTUNITY ON OAHU, HI)
Solicitation # RFI-PGI-20260929
The Department of the Navy is issuing Request for Information RFI-PGI-20260929 to gather industry feedback for the Pacific Greenfield initiative. This effort aims to establish advanced manufacturing and industrial resilience capabilities on existing non-excess Navy property on Oahu, Hawaii. The primary goal is to reduce reliance on long-lead continental United States supply chains by enabling theater-scale production of critical components, including metals, composites, electronics, and large-format printing, with a target capacity of hundreds to thousands of units. The Navy is seeking information on industrial-scale facility concepts, modern manufacturing footprints, and the integration of robust utility infrastructure, such as microgrids and circular resource-recovery systems, while emphasizing the development of the local Hawaii workforce through training pipelines. This RFI is strictly for market research and planning purposes and does not constitute a solicitation or a commitment to award a contract. The Navy is exploring various acquisition and partnership models, including Enhanced Use Leases, Other Transaction Agreements, and joint ventures, to leverage private investment and reduce federal capital requirements. Interested parties, including specialized small businesses, are invited to submit high-level concepts addressing site requirements, financing approaches, and development timelines. Responses are limited to 20 pages and must be submitted by 17:00 HST on November 10, 2026. Potential respondents are cautioned regarding possible organizational conflicts of interest related to the project's advisory and real-estate requirements.
Navfacsyscom Pacific

POSTED

about 12 hours ago

DEADLINE

in 12 days
NAICS: 541715
New
Federal
ACC-DTA Commercial Solutions Opening (CSO)
Solicitation # W912CH-26-S-0001
The Army Contracting Command – Detroit Arsenal (ACC-DTA) Commercial Solutions Opening (CSO), solicitation W912CH-26-S-0001, serves as a rapid-acquisition gateway to transition cutting-edge commercial technologies into active defense programs. This vehicle supports a diverse customer base, including the Intelligence and Security Command (INSCOM) and six Portfolio Acquisition Executives, focusing on the development, integration, and sustainment of ground vehicle systems to enhance Army modernization and readiness. The CSO utilizes a streamlined, merit-based, multi-phased evaluation process consisting of solution briefs, presentations, and commercial solution proposals. Awards may be issued through 2028 via FAR Part 12 commercial procedures or non-FAR agreements, such as transaction agreements under 10 U.S.C. 4022 and Cooperative Agreements under 31 U.S.C. 6305. The solicitation encompasses various Areas of Interest (AoI) targeting critical capabilities, including the FALCONS prototype for long-range reconnaissance, TIGER Readiness for the Abrams Main Battle Tank engine supply chain, Counter-Unmanned Aircraft Systems (C-UAS) detection, and the Light Tactical Trailer Heavy Chassis (LTT-HC). Funding ceilings for specific prototypes, such as FALCONS, range from 24 million to 30 million dollars depending on the use of government-provided kits. Key requirements include strict adherence to the Buy American Act and Specialty Metals clauses, with a prohibition on reliance on adversarial foreign nations for critical minerals. Technical evaluations focus on mission viability, affordability, and schedule realism, while administrative requirements include SAM registration, a Unique Entity ID, and compliance with NIST SP 800-171 for handling controlled unclassified information.
W6QK Acc- Dta

POSTED

about 12 hours ago

DEADLINE

in about 2 years
NAICS: 541715
New
Federal
ARTIFICIAL INTELLIGENCE AND NEXT GENERATION DISTRIBUTED COMMAND AND CONTROL
Solicitation # FA875023S7006
The Department of the Air Force, Air Force Materiel Command, AFRL Rome Research Site, is soliciting research and development for Artificial Intelligence and Next Generation Distributed Command and Control under BAA FA8750-23-S-7006. The primary objective is to transform Joint Force Command and Control capabilities by leveraging AI to enhance battlespace assessment, plan selection, and force monitoring in distributed and contested environments. A significant focus is placed on the Battle Management of AI, which seeks technologies to monitor, adapt, and deploy AI capabilities during mission execution to counter model drift and ensure operational safety. This is an open, two-step BAA effective until August 30, 2028, with total estimated funding of approximately $99 million. Individual awards typically range from $200,000 to $20 million and may be awarded as FAR-based procurement contracts, grants, cooperative agreements, or Other Transactions. Initial submissions are limited to three-page white papers, with formal proposals accepted by invitation only. Evaluation is based on a trade-off process considering overall scientific and technical merit, related experience, solution maturity and openness, and cost realism. Prospective offerors must adhere to strict guidelines, including the Gold Standard Science principles for reproducibility and transparency, and must disclose any potential Organizational Conflicts of Interest. Submissions require a CAGE code, unique entity identifier, and an approved DD Form 2345. The government may provide Government Furnished Software for specific technical areas, and all research must comply with National Industrial Security Program standards for the protection of classified information.
FA8750 Afrl Rik

POSTED

about 12 hours ago

DEADLINE

in almost 2 years

AI Contract Overview

Show more

The HEROES program under ARPA-H aims to improve community health outcomes through innovative, regionally focused payment models that incentivize community-based interventions. The solicitation emphasizes four key health outcome categories: maternal health, heart attack and stroke risk reduction, opioid overdose reduction, and alcohol-related health harms. Applicants must submit separate Solution Summaries and proposals for each outcome category and geographic area, with areas ranging from 500,000 to 5 million people. The solicitation process involves multiple amendments that have progressively clarified requirements, updated templates, and revised submission deadlines, with the latest amendment on October 24, 2024, adjusting the proposal due date and revising the administrative and policy templates within Attachment 2. All questions should be directed through the designated ARPA-H Ask-A-Question portal, and submissions are to be made via the specified online platform by December 10, 2024. The contract is managed by the Department of Health and Human Services, with a focus on fostering innovative solutions to address significant morbidity and mortality rates in targeted health outcomes.

General Info

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

DC, USA

Set-Aside

NONE

Documents

10

ARPA-H-SOL-24-01 Health care Rewards to Achieve Improved OutcomeS (HEROES)

PDF, High priority: read this firstrfp
High

ARPA-H-SOL-24-01 HEROES Amendment 01

PDF, High priority: read this firstamendment
High

ARPA-H-SOL-24-01 HEROES Amendment 2

PDF, High priority: read this firstamendment
High

ARPA-H-SOL-24-01 HEROES Amendment 3

PDF, High priority: read this firstamendment
High

ARPA-H-SOL-24-01 HEROES Amendment 4

PDF, High priority: read this firstamendment
High

ARPA-H-SOL-24-01 Solution Summary Template (Amend 2)

DOCX, High priority: read this firstsow
High

HEROES Program Questions and Answers (April 17, 2024)

PDF, Low priorityq-and-a
Low

ARPA-H-SOL-24-01_Attachment 1_Solution Summary Template_Amendment 1.zip

ZIP

ARPA-H-SOL-24-01_Attachment 1_Solution Summary Template.zip

ZIP

ARPA-H-SOL-24-01 Attachment 2 OT Bundle Amendment 4.zip

ZIP

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

6 updates
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

Response deadline changed from Nov 15, 2024 to Dec 10, 2024. The notice description changed. The point of contact changed.

Notice updated

The notice description changed. The point of contact changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
Contacts1 person available
OfficeWashington, DC, 20005, USA
Office AddressWashington, DC, 20005, USA
Contacts
See Description Section

Full Description

Show more
Amendment 05 (November 15, 2024): The purpose of this Amendment is to: 1) Revise Section 1.6.3, Data Strategy; 2) update the Volume 1: Technical & Management template. Updates to the Technical & Management template largely capture additional information on data and evaluation methods; 3) update the Task Description Document (TDD) template; 4) Provide the model OT agreements per Section 2.0 (d). These models (one AHA and one PHA model) are provided within the Attachment 2, OT Bundle; 4) make administrative updates to Section 1.7, Program Metrics & Milestones, Table 2, Metrics by Health Outcome; and 5) update Section 1.9.2, Program deliverables to account for changes made to Section 1.6.3 and the Technical & Management template. No other changes to the Attachment 2, OT Bundle templates have been made. However, for ease, all Attachment 2, OT Bundle templates are being provided with Amendment 5 and previous versions of Attachment 2, OT Bundle templates have been removed to avoid confusion. Amendment 04 (October 24, 2024): The purpose of this Amendment is to: 1) revise the proposal due date; and 2) to revise the Volume 3 - Admin & National Policy Requirements template provided within the Attachment 2, OT Bundle. All changes are highlighted in yellow. No other changes to the Attachment 2, OT Bundle templates have been made. However, for ease, all Attachment 2, OT Bundle templates are being provided with Amendment 4 and previous versions of Attachment 2, OT Bundle templates have been removed to avoid confusion. Amendment 03 (September 18, 2024): The purpose of this Amendment is to revise Section 1.9 (b), General Requirements, and to make clarifying edits to Section 2.0 (d), Program Selection Award Information, and Section 5.1 (a), Evaluation Criteria for Award. This Amendment also revises the Attachment 2, OT Bundle specifically the Volume 1, Technical and Management template, the Volume 2, Price Template, and the Attachment 2, Volume 2 Price Summary, Research, Proposer financed spreadsheet template. All changes are highlighted in yellow within the solicitation and attachment templates. Updated versions of the Volume 2, Price Template and the Price Summary, Research Proposer financed spreadsheet template are provided. Changes made within these documents are to clarify intent and streamline the level of detail requested. No other changes to the Attachment 2, OT Bundle have been made. However, a revised Attachment 2, OT Bundle is provided. Proposers should use the Attachment 2, OT Bundle provided within Amendment 3. Amendment 02 (June 14, 2024): The purpose of this Amendment is to: 1) Provide clarifying details to Section 1.9.2, Program Deliverables; 2) Provide clarifying details to Sections 4.2.1 and 4.3.1 (b); and 3) Update the Solution Summary template (Attachment 1). All changes are highlighted in yellow within the solicitation and the Solution Summary Template. No changes have been made to the OT Bundle (Attachment 2) in Amendment 02. For ease, the current versions of the templates included within the OT Bundle (Attachment 2) are provided via Amendment 02. See ARPA-H-SOL-24-01 through Amendment 02 documents attached. Amendment 01 (May 24, 2024): The purpose of Amendment 1 is as follows: 1) update Section 7.0 of the solicitation to state the Q&A will post only to the HEROES Team webpage; 2) clarify when the model OT will be provided in Section 2 (d) of the solicitation; 3) update the Solution Summary template (Attachment 1) Section 3 (d); 4) update Attachment 2, Volume 2, Price to remove reference to - fully burdened in Section III, Price Details (Proposer financed component); 5) provide an updated Attachment 2, Volume 2 Price Summary, Research, Proposer financed spreadsheet. References to - fully burdened have been removed throughout the spreadsheet; and 6) provide an updated Attachment 2, Volume 2 Prime Summary, Fixed Component spreadsheet to add clarification regarding - fully burdened rates found in note 6A of the template. All changes are highlighted in yellow. Unless modified within Amendment 01, all remaining attachments within the OT bundle (Attachment 2) remain unchanged. See ARPA-H-SOL-24-01 through Amendment 01 documents attached. Under the HEealth care Rewards to Achieve Improved OutcomES (HEROES) program, public health entities and collaborators will have the opportunity to improve the health status of their communities for specific patient populations through the use of a payment model that incentivizes community-based interventions to improve health outcomes across a fixed geographic area. These solutions will investigate a new, regionally focused, outcomes-based financing approach for the healthcare industry, which rewards only positive health outcomes and reduces the healthcare burden on patients, providers, and the economy. The HEROES solicitation highlights four specific health outcomes of interest to the program. These outcome categories were selected because of their significant morbidity and mortality rates despite the availability of effective, evidence-based interventions to prevent such circumstances or reduce their severity. The four outcome categories are as follows: Maternal Health: Reduction in rate of intrapartum and postpartum severe obstetric complications per 10,000 deliveries. Heart Attack and Stroke Risk: Reduction in the aggregate 10-year risk of heart attack and stroke for people aged 40-70 years. Opioid Overdose: Reduction in the rate of emergency medical services (EMS) patient encounters for fatal and non-fatal opioid overdoses per 100,000 population. Alcohol-Related Health Harms: Reduction in the rate of EMS patient encounters for alcohol-related emergencies per 100,000 population. Proposers will select one of the four health outcome categories in geographic areas ranging from 500,000 to 5 million people in the general population. Solution Summaries MUST be submitted in advance of a full proposal, and Proposers interested in proposing to more than one health outcome category MUST submit a separate Solution Summary and proposal for each outcome category/ geographic area pairing. All questions technical or administrative shall be submitted to ARPA-H Ask-A-Question: https://solutions.arpa-h.gov/Ask-A-Question/. E-mails sent directly to the Program Manager, or any other address will be discarded. All Solution Summary submissions shall be submitted to: https://solutions.arpa-h.gov by the date and time stipulated in the HEROES solicitation All proposal submissions shall be submitted to: https://solutions.arpa-h.gov/Submit-Proposal/ by the date and time stipulated in the HEROES solicitation An updated Q&A document, Rev 2 dated April 17, 2024 is attached. See attached solicitation.

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541715
New
Federal
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
Solicitation # ARPA-H-SOL-26-163
The Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, issued by the Advanced Research Projects Agency for Health (ARPA-H) under solicitation ARPA-H-SOL-26-163, aims to advance the understanding and treatment of autism by identifying evolving developmental trajectories across the lifespan. The program focuses on the nonlinear interactions between genetic, biological, behavioral, and environmental factors to move toward personalized intervention. The scope of work is divided into four Technical Areas: Multi-Factor Analysis and Trajectory Identification (TA1), Population-Scale Modeling and Data Integration (TA2), Precision Intervention and Trajectory Testing (TA3), and Technologies for Communication, Quality of Life, and Embedded Assessment (TA4). Key deliverables include an operating federated network with at least ten live nodes, open-license data standards, a versioned model registry, and the development of technologies that combine clinical assessment with tools to improve daily function and quality of life. Awards will be made via Other Transaction (OT) instruments to proposers determined to be the most advantageous to the government based on scientific merit, capabilities, price/value analysis, and relevance to the ARPA-H mission. The program utilizes a milestone-based acceptance process with gates at 12, 24, and 48 months. Technical requirements emphasize privacy-preserving linkage, differential privacy, and secure execution. Proposers must be registered in SAM.gov and are required to use specific templates for Solution Summaries, with staggered submission deadlines ranging from October 2026 through January 2027. ARPA-H prioritizes entities that will conduct the funded work within the United States.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 12 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, seeks to identify and engage early-career investigators to develop cutting-edge biomedical, health, and community-engaged research. This opportunity is open to researchers from academic, nonprofit, and industry organizations, provided the Principal Investigator is within eight years of completing their first terminal degree. The initiative covers 16 specific topic areas, including AI in life sciences, brain stimulation, and human tissue platforms. Awards are issued as Other Transaction (OT) agreements, which are not subject to the Federal Acquisition Regulation (FAR). The selection process is a two-step submission involving an initial anonymized Solution Summary and a subsequent Full Proposal for selected candidates. Successful awards have a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a 24-month base period capped at 700,000 dollars and an optional 12-month Director's Award period capped at 350,000 dollars. Payments are structured as fixed payments triggered by the completion of 12 discrete, measurable milestones. Full proposals are evaluated based on technical merit, innovativeness, feasibility, alignment with the ARPA-H mission to accelerate health outcomes, and price reasonableness. Administrative requirements include mandatory registration in SAM.gov and the use of the ARPA-H Solutions site for all submissions. Proposers must adhere to strict formatting templates for technical and management proposals, milestone schedules, and national policy requirements, including disclosures regarding organizational conflicts of interest and research security. Performance is monitored through a formal inspection and acceptance process where the government reviews deliverables within 14 calendar days. The tentative award start date is June 30, 2027, with full proposals due by February 10, 2027.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

in 3 months
View Details
NAICS: 541715
Federal
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-160
The Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program, under solicitation ARPA-H-SOL-26-160, is an initiative by the Advanced Research Projects Agency for Health (ARPA-H) to develop a near real-time, non-destructive, AI-enabled screening system. The goal is to identify contamination, adulteration, and quality defects in pharmaceutical products through their packaging at ports of entry and other supply-chain nodes using multi-modal sensing and data fusion. This 54-month program is structured into three 18-month phases, culminating in a fieldable platform with validated training materials and integrated documentation capabilities. This procurement is conducted as a multiple-award Other Transaction (OT) Agreement rather than a standard federal contract, meaning it is governed by specific OT articles instead of the Federal Acquisition Regulation. Awards are based on the most advantageous proposals, with primary evaluation factors including innovation, soundness, execution planning, risk management, and team expertise. Payments are fixed and triggered by the successful completion of milestones, managed through the Payment Management System. Proposers must be registered in SAM.gov and provide detailed technical and cost proposals, including a milestone payment schedule and research security disclosures. Amendment 01 specifically updated the cost proposal narrative model and workbook to correct typographical errors and rename appendices.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

8 days ago

DEADLINE

in 12 days
View Details
NAICS: 541714
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

29 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the UNifying Imaging with QUantum Entanglement (UNIQUE) program, solicitation number ARPA-H-SOL-26-162. This 18-month, two-phase initiative aims to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data using quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: the Imaging Core, which focuses on physical systems for generating and measuring quantum observables, and the Computational Foundation, which focuses on AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction Agreements to eligible universities, non-profit organizations, and businesses. The submission process is two-staged, requiring Solution Summaries by late October 2026 and Full Proposals by December 15, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on technical innovation and feasibility, proposer expertise, potential to transform biomedicine, and cost reasonableness. Notably, for-profit organizations that are not small businesses under NAICS 541714 are required to provide a meaningful cost share. All participants must adhere to strict HHS regulations regarding human stem cell research and prohibitions on dangerous gain-of-function research and funding for foreign entities in countries of concern.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS